Sonoco Increases Quarterly Stock Dividend From $0.51 To $0.52 Per Share

The Board of Directors of Sonoco (NYSE:SON) today increased its quarterly common stock dividend to $0.52 per share from the previous quarterly distribution of $0.51 per share. This new

The Board of Directors of Sonoco (NYSE:SON) today increased its quarterly common stock dividend to $0.52 per share from the previous quarterly distribution of $0.51 per share. This new dividend will be paid on June 10, 2024, to shareholders of record as of May 10, 2024.

 

With this increase, Sonoco’s annualized dividend payout moves to $2.08 per share. Future quarterly declarations and the establishment of future record and payment dates are subject to final determination by Sonoco’s Board of Directors.

According to Howard Coker, President and Chief Executive Officer, this is the 396th consecutive quarter and 99th, year dating back to 1925, that the Company has paid dividends to shareholders, and is the 41st consecutive year the Company has increased its annualized dividend. Based on the closing price of Sonoco’s common stock on April 15, 2024, the Company’s dividend provides an approximate 3.6 percent yield, which is more than double the dividend yield of the S&P 500 Index.

Total
0
Shares
Related Posts
Read More

Australian Market Opens Up To Clever Leaves With GMP Certification For Cannabis Manufacturing

Colombian medical cannabis company Clever Leaves has been granted Good Manufacturing Practice (GMP) certification by the Australian Therapeutic Goods Administration (TGA). The certification allows Clever Leaves to manufacture cannabis products for patients in Australia. GMP certification ensures the quality and safety of pharmaceutical products by safeguarding against issues such as contamination, compound variations, product mix-ups, and incorrect labelling. The certification is a prerequisite for manufacturing and commercialising cannabis products in the Australian market. According to TGA data, 325,000 new Australian patients commenced cannabis treatment in the first half of 2023, with 320,000 new patients in 2022 and 150,000 in 2021. Clever Leaves already distributes finished cannabis products in Australia through its partners.

CLVR